Investment
Features
FeesSafety
Academy
More
Pluang+

Compare InMode Ltd (INMD) vs Msci Inc (MSCI) Price & Performance

InMode LtdTrade

Price performance (Past 24H)

Key statistics

InMode Ltd vs Msci Inc — how do they compare? InMode Ltd trades at $14.21 (market cap $809.93M), while Msci Inc trades at $565.12 (market cap $40.38B). The key difference: Msci Inc is far larger — about 49.9× InMode Ltd's market cap, and Msci Inc pays a 1.48% dividend while InMode Ltd pays none. Which is the better fit depends on your goals — on Pluang, investors hold InMode Ltd for 28 Days and Msci Inc for 82 Days on average.

INMDMSCI
Market Cap
$809.93M$40.38B
Volume
365,490414,140
Sector
HealthFinancials
52-Week High
$16.62$643.83
52-Week Low
$12.76$511.84
Typical Hold Time
28 Days82 Days
Enterprise Value
$313.27M$46.54B
Dividend Yield
—1.48%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

InMode Ltd

INMD trades at $14.08, up 0.5% with mixed technical signals showing bearish moving averages but neutral oscillators. The company maintains strong fundamentals with a P/E of 11.63, gross margins of 76.52%, and consistent revenue around $370M. Recent news includes product innovation with Morpheus8 Cool launch and an unsolicited acquisition offer from Steel Partners at $16.75 per share in July 2026.

Outlook remains cautious with analyst consensus divided (45% Buy, 55% Hold) amid cyclical softness. Investment opportunity lies in potential acquisition premium and international growth, while risks include US sales decline and management capital allocation concerns. The stock faces near-term resistance at $14 with support at the same level.

Msci Inc

MSCI trades at $561.67, up 1.13% in 24 hours, with a bullish technical signal and strong fundamental performance. The stock has exceeded earnings expectations in recent quarters, with Q3 2026 results pending. Revenue growth is steady, supported by high profit margins and recurring subscription income. Recent news highlights the completion of the First Street acquisition and upcoming earnings call, reinforcing positive business momentum.

The outlook for MSCI remains favorable, driven by robust earnings, analyst consensus of a buy rating, and a price target implying significant upside. Key risks include high valuation multiples and market sensitivity to financial services demand. Investors should weigh strong profitability against potential volatility from economic cycles.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

INMD
100% Buy0% Sell
Avg holding period · 28 Days
MSCI
2% Buy98% Sell
Avg holding period · 82 Days

About InMode Ltd

InMode provides innovative medical technologies for minimally invasive surgical procedures. Its platforms use radiofrequency (RF) energy for aesthetic treatments like body contouring and skin tightening.

Read more on INMD →

About Msci Inc

MSCI describes its mission as enabling investors to build better portfolios for a better world. MSCI's largest and most profitable segment is its index segment, where it provides benchmarking to asset managers and asset owners. In addition, it boasts over $1 trillion in ETF assets linked to MSCI indexes. The MSCI analytics segment provides portfolio management and risk management analytics software to asset managers and asset owners. MSCI's all other segment was broken out into ESG and climate and private assets segments in 2021. In ESG and climate, MSCI provides ESG data to the investment industry. In the private assets side, MSCI provides real restate reporting, market data, benchmarking, and analytics to investors and real estate managers.

Read more on MSCI →